rs111413308

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001145536.2(C17orf107):​c.*1350G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00685 in 1,215,460 control chromosomes in the GnomAD database, including 444 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.034 ( 279 hom., cov: 32)
Exomes 𝑓: 0.0031 ( 165 hom. )

Consequence

C17orf107
NM_001145536.2 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.579

Publications

2 publications found
Variant links:
Genes affected
C17orf107 (HGNC:37238): (chromosome 17 open reading frame 107)
CHRNE (HGNC:1966): (cholinergic receptor nicotinic epsilon subunit) Acetylcholine receptors at mature mammalian neuromuscular junctions are pentameric protein complexes composed of four subunits in the ratio of two alpha subunits to one beta, one epsilon, and one delta subunit. The acetylcholine receptor changes subunit composition shortly after birth when the epsilon subunit replaces the gamma subunit seen in embryonic receptors. Mutations in the epsilon subunit are associated with congenital myasthenic syndrome. [provided by RefSeq, Sep 2009]
CHRNE Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: Illumina
  • congenital myasthenic syndrome 4A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • congenital myasthenic syndrome 4B
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • congenital myasthenic syndrome 4C
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 17-4901883-G-A is Benign according to our data. Variant chr17-4901883-G-A is described in ClinVar as Benign. ClinVar VariationId is 254900.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.115 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C17orf107NM_001145536.2 linkc.*1350G>A 3_prime_UTR_variant Exon 3 of 3 ENST00000381365.4 NP_001139008.1
CHRNENM_000080.4 linkc.500+49C>T intron_variant Intron 5 of 11 ENST00000649488.2 NP_000071.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C17orf107ENST00000381365.4 linkc.*1350G>A 3_prime_UTR_variant Exon 3 of 3 2 NM_001145536.2 ENSP00000370770.3
CHRNEENST00000649488.2 linkc.500+49C>T intron_variant Intron 5 of 11 NM_000080.4 ENSP00000497829.1

Frequencies

GnomAD3 genomes
AF:
0.0337
AC:
4946
AN:
146694
Hom.:
272
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.117
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0159
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000856
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0161
Gnomad NFE
AF:
0.000573
Gnomad OTH
AF:
0.0225
GnomAD2 exomes
AF:
0.00890
AC:
2161
AN:
242944
AF XY:
0.00674
show subpopulations
Gnomad AFR exome
AF:
0.119
Gnomad AMR exome
AF:
0.00883
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000459
Gnomad OTH exome
AF:
0.00675
GnomAD4 exome
AF:
0.00314
AC:
3356
AN:
1068652
Hom.:
165
Cov.:
28
AF XY:
0.00271
AC XY:
1478
AN XY:
544962
show subpopulations
African (AFR)
AF:
0.0902
AC:
2304
AN:
25542
American (AMR)
AF:
0.00959
AC:
413
AN:
43084
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22804
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36030
South Asian (SAS)
AF:
0.000397
AC:
31
AN:
78144
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49212
Middle Eastern (MID)
AF:
0.00549
AC:
20
AN:
3646
European-Non Finnish (NFE)
AF:
0.000268
AC:
205
AN:
764032
Other (OTH)
AF:
0.00830
AC:
383
AN:
46158
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
131
262
394
525
656
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0339
AC:
4975
AN:
146808
Hom.:
279
Cov.:
32
AF XY:
0.0324
AC XY:
2316
AN XY:
71552
show subpopulations
African (AFR)
AF:
0.117
AC:
4646
AN:
39542
American (AMR)
AF:
0.0158
AC:
237
AN:
14974
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3432
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4908
South Asian (SAS)
AF:
0.000642
AC:
3
AN:
4674
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9688
Middle Eastern (MID)
AF:
0.0172
AC:
5
AN:
290
European-Non Finnish (NFE)
AF:
0.000573
AC:
38
AN:
66356
Other (OTH)
AF:
0.0223
AC:
46
AN:
2064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
208
417
625
834
1042
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00241
Hom.:
3
Bravo
AF:
0.0386
Asia WGS
AF:
0.00898
AC:
31
AN:
3468

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Oct 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.6
DANN
Benign
0.79
PhyloP100
0.58
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111413308; hg19: chr17-4805178; API